Citadel Advisors
NTBL

Citadel Advisors’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Citadel Advisors’s Portfolio NTBL Stock Details NTBL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-849
Closed -$61K – 14985
2021
Q3 		$61K Buy
849
+43
+5% +$3.35K ﹤0.01% 13256
2021
Q2 		$67K Buy
806
+492
+157% +$37.3K ﹤0.01% 13193
2021
Q1 		$22K Sell
314
-23
-7% -$1.79K ﹤0.01% 13068
2020
Q4 		$22K Buy
+337
New +$16.1K ﹤0.01% 10766
2018
Q2 		– Sell
-386
Closed -$31K – 9389
2018
Q1 		$31K Buy
+386
New +$77.8K ﹤0.01% 8046

Other funds holding NTBL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
ACA
Affinity Capital Advisors Berkeley, California $810M AUM 24.85% 1-Year Est. Return
HSA
HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SPAS
Spectrum Planning & Advisory Services San Diego, California $223M AUM 17.29% 1-Year Est. Return

Citadel Advisors's NTBL Position: Q1 2023 in Review

Citadel Advisors sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q1 2023, closing a stake of 3,666 shares — an estimated $15.4K sold.

Citadel Advisors first reported a position in NTBL in Q1 2017 and held it in 12 quarters. The position peaked at $303K in Q2 2021. 18 funds tracked by Wall St. Rank hold NTBL as of Q1 2023.

  • Citadel Advisors reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 3,666 Notable Labs, Ltd. Ordinary Shares shares in Q1 2023, an estimated $15.4K.
  • Citadel Advisors first reported a position in Notable Labs, Ltd. Ordinary Shares in Q1 2017 and held it in 12 quarters.
  • Citadel Advisors's Notable Labs, Ltd. Ordinary Shares position peaked at $303K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.